VALIDATION IMAGES
Paraformaldehyde-fixed and paraffin-embedded Human tonsil tissue incubated with Cyclin A2 (2C2) Monoclonal Antibody (bsm-52660R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Paraformaldehyde-fixed and paraffin-embedded Human colon cancer tissue incubated with Cyclin A2 (2C2) Monoclonal Antibody (bsm-52660R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Paraformaldehyde-fixed and paraffin-embedded Mouse colon tissue incubated with Cyclin A2 (2C2) Monoclonal Antibody (bsm-52660R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Paraformaldehyde-fixed and paraffin-embedded Human breast carcinoma tissue incubated with Cyclin A2 (2C2) Monoclonal Antibody (bsm-52660R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Lane 1: Human HeLa cell lysates; Lane 2: Human Jurkat cell lysates; Lane 3: Human MOLT4 cell lysates; Lane 4: Human HL-60 cell lysates probed with CCNA2 Monoclonal Antibody, Unconjugated (bsm-52660R) at 1:1000 dilution and 4°C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.